Clinical Trial Result Information

Protocol number
ML17225

Title of Study
This is an open-label, prospective, randomized, controlled multi-center study assessing fixed dose vs concentration controlled CellCept® regimens for patients following a single organ renal transplantation in combination with full dose and reduced dose calcineurin inhibitors

Sponsor
Roche Laboratories Inc.

Company division
Pharmaceutical

Product name
CellCept

Generic name
mycophenolate mofetil

Therapeutic area
Kidney Transplantation

Clinical study summary
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.

Phase of development
IV

Date of report
To be Published

Click here for the protocol registry listing of this trial.